tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market

Xeris Pharmaceuticals (XERS) Cash flow

Compare
976 Followers

Xeris Pharmaceuticals Cash Flow

XERS's free cash flow for Q4 2024 was $1.75M. For the 2024 fiscal year, XERS's free cash flow was decreased by $11.44M and operating cash flow was $1.98M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -36.98M$ -47.02M$ -102.89M$ -102.89M$ -95.53M
Investing Cash Flow
$ 4.88M$ -6.00M$ 34.46M$ 34.46M$ 97.96M
Financing Cash Flow
$ 36.17M$ -1.61M$ 127.47M$ 127.47M$ 27.25M
End Cash Position
$ 75.74M$ 71.67M$ 126.31M$ 126.31M$ 67.27M
Free Cash Flow
$ -37.85M$ -49.29M$ -103.42M$ -103.42M$ -96.62M
Currency in USD

Xeris Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis